KLTO

Klotho Neurosciences (KLTO)

About Klotho Neurosciences (KLTO)

Klotho Neurosciences, Inc. engages in the provision of new therapies to treat neurodegenerative diseases. It offers cell and gene therapy. The company was founded by Joseph Sinkule on August 2, 2004 and is headquartered in Omaha, NE.

Details

Daily high
$0.51
Daily low
$0.46
Price at open
--
52 Week High
$3.91
52 Week Low
$0.11
Market cap
35.5M
Dividend yield
0.00%
Volume
2,592
Avg. volume
727,306
P/E ratio
-1.50

Klotho Neurosciences News

Details

Daily high
$0.51
Daily low
$0.46
Price at open
--
52 Week High
$3.91
52 Week Low
$0.11
Market cap
35.5M
Dividend yield
0.00%
Volume
2,592
Avg. volume
727,306
P/E ratio
-1.50